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or Fine-Tuning?
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The skin has recently been found to be an extra-adrenal site for glucocorticoid
(GC) synthesis that likely acts to modulate local inflammation. Psychological,
physiological, and physical stress, both acute and chronic, triggers immune-
protective or -damaging responses, including increases in systemic GC levels,
which, according to Lin et al. (this issue), may be beneficial in inflammatory skin
disease. However, little is known about the interplay between local and systemic
production of GCs and the effect of stress (local or systemic) in regulating tissue-
specific GC synthesis, its impact on skin homeostasis, and its effect of skin disease.
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Skin is an extra-adrenal source of cortisol
Endocrine responses to stress occur
systemically, under control of the CNS,
but also locally as tissue-specific res-
ponses. The concept of skin as an
endocrine organ is well established
(Slominski et al., 2008). All major
components of the hypothalamic–
pituitary–adrenal (HPA) axis, corticotro-
phin-releasing hormone (CRH), its
receptor CRH-R, urocortin, propiomela-
nocortin (POMC), adrenocorticotropic
hormone (ACTH), and melanocortin
receptors, are produced in the skin
(Slominski et al., 2008). The skin
expresses receptors for neurotransmitters
and for steroid, retinoid, and thyroid
hormones. In addition, the skin is able
to metabolize, activate, and inactivate
hormones. Keratinocytes synthesize
cholesterol de novo, a precursor to all
steroids. However, recent findings from
our laboratory and others have found the
skin to be a major site of extra-adrenal
cortisol synthesis (Figure 1a), but this fact
appears to have garnered little notice,
despite its potential clinical impact
(Vukelic et al., 2011; Slominski et al.,
2013). For example, major skin compart-
ments, epidermis, dermis, melanocytes,
and hair follicles, have been shown to
synthesize cortisol (Vukelic et al., 2011;
Slominski et al., 2013). As expected,
enzymes that control cortisol activity,
11b-hydroxysteroid dehydrogenase type
1 and 2, are also expressed in the skin
(Tiganescu et al., 2014), and in a time-
dependent manner they control cortisol
levels through positive- and negative-
feedback mechanisms. Furthermore,
glucocorticoid (GC) receptor, by which
GCs transmit their signals, is found in
most, if not all, skin compartments,
including epidermal and follicular
keratinocytes, epithelial cells of eccrine
and apocrine glands, sebocytes, melano-
cytes, immune cells of the epidermis and
dermis, dermal fibroblasts, and smooth
muscle cells (Slominski et al., 2008,
2013). However, little is known about
the role of this local HPA axis and
cortisol synthesis in the context of
acute and chronic inflammatory skin
diseases (Figure 1). Furthermore, as
cortisol production in the skin appears
constitutive and is tightly controlled by
local mechanisms, how this independent
cortisol-producing system responds to
changes in systemic GC levels (such as
circadian rhythm, psychological stress),
or externally administered systemic and
topical GC therapy, is likely to be
See related article on pg 2890 important. Lin et al. (2014) in this issue
address one of these questions: the intri-
cacy of acute psychological stress in the
context of systemic GC function and its
role in inflammatory skin disease.
The effects of local and systemic stress on
skin function and local cortisol synthesis
Barrier-forming tissues, including the
skin, lungs, and gut, all possess protec-
tive inflammatory mechanisms when its
barrier is compromised. Moreover, these
tissues all function while surrounded by
commensal microbiome, and they are
often challenged by physical, chemical,
and biological injury, such as occurs
after skin wounding, UV radiation expo-
sure, or invasion by pathogenic micro-
organisms. The skin produces neural
(rapid) or humoral (slower) signals to
prompt responses at systemic and organ-
specific levels. These responses are
designed to counteract the detrimental
consequences of environmental insults
or to restore homeostasis, thereby pro-
viding optimal safeguards against harm-
ful environmental agents (Slominski
et al., 2008, 2013). Systemically, the
HPA axis provides adaptive responses
that stabilize and restore global homeo-
stasis when prompted by disease or
stress (psychological and/or physiological)
through regulation of cortisol secretion
by targeting CRH and ACTH (Figure 1b)
(Slominski et al., 2008). As an example,
systemically CRH expression and serum
levels of CRH are increased under patho-
logical conditions, including immune
and inflammatory disorders such as
psoriasis and atopic dermatitis (AD).
Furthermore, serum levels of CRH have
been found to be increased in patients
with psoriasis and AD, skin diseases that
can worsen with stress (Hunter et al.,
2013; Wikramanayake et al., 2014). At
the same time, locally produced lipopo-
lysaccharides (LPSs) can stimulate CRH
production, mediating LPS-induced
inflammation in keratinocytes. UVB
radiation can also stimulate CRH
expression and POMC-derived peptide
(ACTH, b-endorphin, and a-melanocyte–
stimulating hormone) production in
melanocytes, keratinocytes, and fibro-
blasts (Slominski et al., 2013).
Robust inflammatory responses are
important aids to epidermal barrier
restoration and maintenance (Pastar
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et al., 2014). Thus, inflammation is a
double-edge sword, beneficial when
produced at the right time and in the
appropriate amount, but potentially
damaging if prolonged thus contribut-
ing to the disease itself, including delay
of wound healing (Hunter et al., 2013;
Wikramanayake et al., 2014). Thus, as a
response to inflammation, local and
systemic GCs may prevent excessive
inflammation upon initial injury, by
modulating the inflammatory response
(Pastar et al., 2014). The case in point
is the epidermal response to wounding
that triggers local (epidermal) synthesis of
cortisol, which is regulated directly by
pro-inflammatory cytokines (IL-1) as a
timed, negative-feedback mechanism,
one that curbs local inflam-
mation (Figure 1b). Furthermore, as a
circular loop, inhibition of GC synthesis
in keratinocytes results in augmented
expression of IL-1b (Vukelic et al.,
2011). This is an example of fine-tuning
between pro- and anti-inflammatory sig-
nals that govern the function of the skin
and contribute to barrier maintenance.
In addition to GC production (as a
result of psychological stress), psycho-
logical stress also results in adrenal
catecholamine release. This may be
beneficial in the short term by increas-
ing the pulse, respiratory rate, and
blood pressure, but it may be detrimen-
tal in the long term by producing DNA
damage, immunosuppression, tumor
growth, dementia, and cardiovascular
disorders. Acute stressors are thought
to be beneficial by mobilizing immune
cells, stimulating their migration to
injured tissues and increasing both cel-
lular and humoral adaptive immunity,
whereas recurring acute or chronic
stress is thought to be detrimental to
the body’s ability to battle disease, pre-
serve homeostasis, and defend against
aging caused by elevated levels of GCs
(Dhabhar 2013).
Where is a paradox: too much of a bad
thing can be beneficial?
Despite the needed acute stress
responses, chronic stress suppresses
immune function and increases the
predisposition to infection, primarily by
immune-suppressive GC effects. One
might expect long-term, elevated GC
caused by chronic stress to amelio-
rate immune and inflammatory skin
diseases (e.g., psoriasis, AD). Interest-
ingly, stress has been shown to have
the opposite effect (Dhabhar, 2013).
This paradox is complicated further
by the differing effects of chronic stress
(lasting for weeks/months/years) and
acute stress (lasting for minutes to
hours). The new study (Lin et al., 2014)
has shown that acute psychological
stress–induced elevations in endo-
genous systemic GCs can benefit, rather
than aggravate, cutaneous function
and reduce inflammation. Using three
immunologically diverse mouse models
of inflammatory disease, irritant contact
dermatitis (ICD), acute allergic contact
dermatitis, and repeated hapten chal-
lenge in a model of chronic allergic
contact dermatitis with features of AD,
the investigators found that imposition
of exogenous stress exerts potent anti-
inflammatory activity (reductions in
IL-1a and IL-6), thus improving both
barrier function and stratum corneum
hydration, all of which is mediated by
a rise in endogenous GCs (Figure 1b).
This systemic GC protective effect, in
contrast to the existing literature, sug-
gests that the stress effects of increased
endogenous GCs compromise perme-
ability barrier homeostasis, stratum
corneum adhesion, wound healing,
and epidermal innate immunity in nor-
mal skin (Stojadinovic et al., 2012).
Possibly, the differences in results lie in
responses that originate from normal as
opposed to inflamed skin. Furthermore,
Lin et al. (2014) assert that, when
psychological stress induces cutaneous
inflammatory disorders (as is the case
with systemic lupus erythematosus,
inflammatory bowel disease, and
allergic asthma, psoriasis, or AD), it
does so not only by compromising
epithelial barrier function, cell–cell
cohesion, and proliferation and differen-
tiation but also by compromising innate
immunity, in turn facilitating bac-
terial colonization, translocation, and
invasion by pathogens. Inhibition of
systemic GC effects by the receptor
antagonist mifepristone intensified epi-
dermal hyperplasia and inflammation in
both ICD and AD mouse models in the
presence of stress (Lin et al., 2014),
suggesting the beneficial effects of
stress-induced GCs. In addition, compli-
cating this set of experiments are the
obvious differences between rodents
and humans as well as differences in
their skin. Mice are nocturnal animals
and hence have very limited exposure to
solar radiation, whereas human skin is
exposed routinely during the day to UV
radiation, stimulating the production of
CRH (Slominski et al., 2008). In addi-
tion, mouse skin CRH is dependent on
rodent hair follicle cycling, and their
fur-coated skin is shielded somewhat
from environmental stressors, thereby
relieving it from evolutionary pressure
Clinical Implications
 Acute psychological stress may have beneficial effects on the epidermal
barrier function in patients with inflammatory skin disease.
 Endogenous cortisol production in skin may influence the effect of
systemic endogenous glucocorticoids produced as a result of stress and
the effect of exogenous glucocorticoids delivered as therapy.
Figure 1. Local and systemic effects of pro- and anti-inflammatory, with cross talk triggered by acute and
chronic stress. The cell represents any type of skin cell capable of cortisol synthesis. (a) In the absence of
stress, the skin produces cortisol locally and is exposed to circadian-dependent influx of systemic cortisol.
(b) In acute stress, local pro-inflammatory signals induce cortisol synthesis. Acute psychological stress
triggers influx of systemic cortisol that may have dual effects on systemic inflammatory responses: it may
compromise immunity in healthy skin, whereas, as shown by Lin et al. (2014), it may reduce inflammatory
responses to non-pathogenic levels in patients with inflammatory skin diseases. (c) Chronic psychological
stress triggers prolonged systemic cortisol that results in increased reactive oxygen species (ROS) and DNA
damage. The question mark indicates our lack of understanding about how both acute and chronic stress
influence endogenous cortisol synthesis in the skin. ACTH, adrenocorticotropic hormone; CRH,
corticotrophin-releasing hormone; GR, glucocorticoid receptor.
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to cultivate an epidermal corticotropin
releasing hormone receptor 1–centered
stress response system.
Chronic psychological stress, in addi-
tion to stimulating HPA axis (GC
release) and the autonomic nervous
system (catecholamine release), also
stimulates the renin–angiotensin system,
seemingly as the body tries to resolve
perceived threats to homeostasis
(Stojadinovic et al., 2012). Prolonged
activation of these pathways can lead
to chronic immune dysfunction, increa-
sed production of reactive oxygen
species (ROS), and DNA damage, all
of which promote aging (in the skin
as well as in other tissues). Although
GCs are notorious for being largely
immunosuppressive, renin and angio-
tensin, which are generated as a
reaction to chronic stress, could permit
pro-inflammatory conditions to persist
in the setting of immunosuppression due
to increased ROS and angiotensin-II-
mediated increases in NFkB activity
and pro-inflammatory cytokines. The
end result of the constant release of
pro-inflammatory cytokines could cause
indiscriminate skin damage, compoun-
ded by the failure of the adaptive system
to respond precisely to infection or
disease. In the context of chronic stress,
cholinergic suppression of antimicro-
bial activity in the setting of catechol-
amine and GC-induced immunosuppres-
sion as well as angiotensin-induced
inflammation may further contribute to
the persistently active but ineffective
immune response (Figure 1c) (Dunn and
Koo, 2013). How all these important
effects of both acute and chronic stress
impact endogenous synthesis, the effect of
exogenously delivered GCs, and activity
of cortisol in the skin is yet to be under-
stood. Such complexity and interplay of
local and systemic neuroendocrine and
immune systems supports the notion that
there may be multiple scenarios in which
acute or even chronic stress may trigger
beneficial response and vice versa.
Clinical impact of GC-based therapies
GCs are widely used as anti-inflamma-
tory drugs, and adverse effects of pro-
longed local and systemic GC treatment
in the skin and in many other tissues are
known to occur (Vukelic et al., 2011).
How acute or chronic stress influences
the beneficial and detrimental effects
of GC therapy is uncertain. Addi-
tional studies are needed to decipher
how acute and chronic psychological or
other types of stress (physical, chemical,
or biological) exert beneficial and/or
detrimental effects in the context of
endogenous GC synthesis and on the
local (skin) and central HPA axes.
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